Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Jefferis

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Biotechnology & Genetic Engineering Reviews|March 19, 2011
The antibody paradigm: present and future development as a scaffold for biopharmaceutical drugsRoy Jefferis
Journal of Immunology Research|May 19, 2016
Posttranslational Modifications and the Immunogenicity of BiotherapeuticsRoy Jefferis
Expert Opinion on Therapeutic Patents|May 16, 2009
Aglycosylated antibodies and the methods of making and using them: WO2008030564Roy Jefferis
Nature Reviews. Drug Discovery|February 28, 2009
Glycosylation as a strategy to improve antibody-based therapeuticsRoy Jefferis
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2009
Glycosylation of antibody therapeutics: optimisation for purposeRoy Jefferis
Advances in Biochemical Engineering/Biotechnology|October 27, 2017
Recombinant Proteins and Monoclonal AntibodiesRoy Jefferis
Mabs|November 30, 2011
Aggregation, immune complexes and immunogenicityRoy Jefferis
Nature Biotechnology|October 13, 2006
A sugar switch for anti-inflammatory antibodiesRoy Jefferis
Current Pharmaceutical Biotechnology|November 3, 2016
Glyco-Engineering of Human IgG-Fc to Modulate Biologic ActivitiesRoy Jefferis
Advances in Experimental Medicine and Biology|January 13, 2006
Glycosylation of natural and recombinant antibody moleculesRoy Jefferis
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Biotechnology & Genetic Engineering Reviews|March 19, 2011
The antibody paradigm: present and future development as a scaffold for biopharmaceutical drugsRoy Jefferis
Journal of Immunology Research|May 19, 2016
Posttranslational Modifications and the Immunogenicity of BiotherapeuticsRoy Jefferis
Expert Opinion on Therapeutic Patents|May 16, 2009
Aglycosylated antibodies and the methods of making and using them: WO2008030564Roy Jefferis
Nature Reviews. Drug Discovery|February 28, 2009
Glycosylation as a strategy to improve antibody-based therapeuticsRoy Jefferis
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2009
Glycosylation of antibody therapeutics: optimisation for purposeRoy Jefferis
Advances in Biochemical Engineering/Biotechnology|October 27, 2017
Recombinant Proteins and Monoclonal AntibodiesRoy Jefferis
Mabs|November 30, 2011
Aggregation, immune complexes and immunogenicityRoy Jefferis
Nature Biotechnology|October 13, 2006
A sugar switch for anti-inflammatory antibodiesRoy Jefferis
Current Pharmaceutical Biotechnology|November 3, 2016
Glyco-Engineering of Human IgG-Fc to Modulate Biologic ActivitiesRoy Jefferis
Advances in Experimental Medicine and Biology|January 13, 2006
Glycosylation of natural and recombinant antibody moleculesRoy Jefferis
Pageof 4